Page last updated: 2024-10-30

metformin and Adrenal Cortex Cancer

metformin has been researched along with Adrenal Cortex Cancer in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin has been proposed as a novel anti-cancer drug for adrenocortical carcinoma (ACC) based upon Poli's recent preclinical studies that 1."7.85Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study. ( Brown, RE; Buryanek, J; McGuire, MF, 2017)
"Metformin has been proposed as a novel anti-cancer drug for adrenocortical carcinoma (ACC) based upon Poli's recent preclinical studies that 1."3.85Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study. ( Brown, RE; Buryanek, J; McGuire, MF, 2017)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, RE1
Buryanek, J1
McGuire, MF1
Poli, G1
Cantini, G1
Armignacco, R1
Fucci, R1
Santi, R1
Canu, L1
Nesi, G1
Mannelli, M1
Luconi, M1

Other Studies

2 other studies available for metformin and Adrenal Cortex Cancer

ArticleYear
Metformin and Melatonin in Adrenocortical Carcinoma: Morphoproteomics and Biomedical Analytics Provide Proof of Concept in a Case Study.
    Annals of clinical and laboratory science, 2017, Volume: 47, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antioxidants; Biomarkers, Tumor; Drug The

2017
Metformin as a new anti-cancer drug in adrenocortical carcinoma.
    Oncotarget, 2016, Aug-02, Volume: 7, Issue:31

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Antineoplastic Agents; Apoptosis; Caspa

2016